Magnetic resonance imaging of cystic fibrosis lung disease

Journal of Thoracic Imaging

Volumn 28, Issue 3, 2013, Pages 151-159

  Wielpütz, Mark O ^a,b   Eichinger, Monika ^b   Puderbach, Michael ^b  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Cystic fibrosis; Fourier decomposition; Functional imaging; Magnetic resonance imaging; Perfusion imaging

Indexed keywords

HELIUM;

ARTIFICIAL EMBOLISM; BREATH HOLDING; BREATHING MECHANICS; BRONCHIAL ARTERY; BRONCHIECTASIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CONTRAST ENHANCEMENT; DISEASE SEVERITY; EARLY DIAGNOSIS; EMPHYSEMA; EXPIRATORY FLOW RATE; FORCED EXPIRATORY VOLUME; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; HYPOXIC LUNG VASOCONSTRICTION; IMAGE QUALITY; LUNG ALVEOLUS; LUNG BLOOD FLOW; LUNG CYSTIC FIBROSIS; LUNG EMBOLISM; LUNG FIBROSIS; LUNG HEMORRHAGE; LUNG PARENCHYMA; LUNG SCINTISCANNING; LUNG VENTILATION; MULTIDETECTOR COMPUTED TOMOGRAPHY; PATIENT CARE; SPIN LABELING; SURVIVAL;

CYSTIC FIBROSIS; HUMANS; LUNG DISEASES; MAGNETIC RESONANCE IMAGING;

EID: 84877054679     PISSN: 08835993     EISSN: 15360237     Source Type: Journal    
DOI: 10.1097/RTI.0b013e31828d40d4     Document Type: Conference Paper

References (90)

1. Gibson RL, Burns JL, Ramsey BW. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med. 2003;168:918-951
2. Dodge JA, Lewis PA, Stanton M, et al. Cystic fibrosis mortality and survival in the UK: 1947-2003. Eur Respir J. 2007;29:522-526
3. Stern M, Wiedemann B, Wenzlaff P. From registry to quality management: The German Cystic Fibrosis Quality Assessment project 1995 2006. Eur Respir J. 2008;31:29-35
4. Kerem E, Reisman J, Corey M, et al. Prediction of mortality in patients with cystic fibrosis. N Engl J Med. 1992;326: 1187-1191
5. Brody AS, Tiddens HA, Castile RG, et al. Computed tomography in the evaluation of cystic fibrosis lung disease. Am J Respir Crit Care Med. 2005;172:1246-1252
6. Brody AS, Sucharew H, Campbell JD, et al. Computed tomography correlates with pulmonary exacerbations in children with cystic fibrosis. Am J Respir Crit Care Med. 2005;172:1128-1132
7. Terheggen-Lagro S, Truijens N, van Poppel N, et al. Correlation of six different cystic fibrosis chest radiograph scoring systems with clinical parameters. Pediatr Pulmonol. 2003; 35:441-445
8. Terheggen-Lagro SW, Arets HG, van der Laag J, et al. Radiological and functional changes over 3 years in young children with cystic fibrosis. Eur Respir J. 2007;30:279-285
9. de Jong PA, Lindblad A, Rubin L, et al. Progression of lung disease on computed tomography and pulmonary function tests in children and adults with cystic fibrosis. Thorax. 2006;61:80-85
10. Davis SD, Fordham LA, Brody AS, et al. Computed tomography reflects lower airway inflammation and tracks changes in early cystic fibrosis. Am J Respir Crit Care Med. 2007;175:943-950
11. Sly PD, Brennan S, Gangell C, et al. Lung disease at diagnosis in infants with cystic fibrosis detected by newborn screening. Am J Respir Crit Care Med. 2009;180:146-152
12. de Jong PA, Mayo JR, Golmohammadi K, et al. Estimation of cancer mortality associated with repetitive computed tomography scanning. Am J Respir Crit Care Med. 2006;173: 199-203
13. Donadieu J, Roudier C, Saguintaah M, et al. Estimation of the radiation dose from thoracic CT scans in a cystic fibrosis population. Chest. 2007;132:1233-1238
14. Mott LS, Park J, Murray CP, et al. Progression of early structural lung disease in young children with cystic fibrosis assessed using CT. Thorax. 2012;67:509-516
15. PuderbachM, Eichinger M, Haeselbarth J, et al. Assessment of morphological MRI for pulmonary changes in cystic fibrosis (CF) patients: Comparison to thin-section CT and chest x-ray. Invest Radiol. 2007;42:715-725
16. Eichinger M, Heussel CP, Kauczor HU, et al. Computed tomography and magnetic resonance imaging in cystic fibrosis lung disease. J Magn Reson Imaging. 2010;32:1370-1378
17. Puderbach M, Eichinger M. The role of advanced imaging techniques in cystic fibrosis follow-up: Is there a place for MRI? Pediatr Radiol. 2010;40:844-849
18. Eichinger M, Optazaite DE, Kopp-Schneider A, et al. Morphologic and functional scoring of cystic fibrosis lung disease using MRI. Eur J Radiol. 2012;81:1321-1329
19. Wielputz M, Kauczor HU. MRI of the lung: State of the art. Diagn Interv Radiol. 2012;18:344-353
20. Wild JM, Marshall H, Bock M, et al. MRI of the lung (1/3): Methods. Insights Imaging. 2012;3:345-353
21. Puderbach M, Hintze C, Ley S, et al. MR imaging of the chest: A practical approach at 1.5T. Eur J Radiol. 2007;64:345-355
22. Biederer J, Beer M, Hirsch W, et al. MRI of the lung (2/3). Whyy wheny how? Insights Imaging. 2012;3:355-371
23. Biederer J, Mirsadraee S, Beer M, et al. MRI of the lung (3/3)-current applications and future perspectives. Insights Imaging. 2012;3:373-386
24. Helbich TH, Heinz-Peer G, Eichler I, et al. Cystic fibrosis: CT assessment of lung involvement in children and adults. Radiology. 1999;213:537-544
25. Hansell DM, Bankier AA, MacMahon H, et al. Fleischner Society: Glossary of terms for thoracic imaging. Radiology. 2008;246:697-722
26. Loeve M, van Hal PT, Robinson P, et al. The spectrum of structural abnormalities on CT scans from patients with CF with severe advanced lung disease. Thorax. 2009;64:876-882
27. Puderbach M, Eichinger M, Gahr J, et al. Proton MRI appearance of cystic fibrosis: Comparison to CT. Eur Radiol. 2007;17:716-724
28. Optazaite DE, Eichinger M, Niemann A, et al. Visualization of dilated bronchial arteries using contrast-enhanced magnetic resonance angiography in cystic fibrosis patients -correlation to parenchymal lung changes. Am J Resp Crit Care Med. 2010;181:1816
29. Hopkins SR, Wielputz MO, Kauczor HU. Imaging lung perfusion. J Appl Physiol. 2012;113:328-339
30. Ley S, Puderbach M, Fink C, et al. Assessment of hemodynamic changes in the systemic and pulmonary arterial circulation in patients with cystic fibrosis using phasecontrast MRI. Eur Radiol. 2005;15:1575-1580
31. Vonk-Noordegraaf A, Marcus JT, Holverda S, et al. Early changes of cardiac structure and function in COPD patients with mild hypoxemia. Chest. 2005;127:1898-1903
32. Brinson GM, Noone PG, Mauro MA, et al. Bronchial artery embolization for the treatment of hemoptysis in patients with cystic fibrosis. Am J Respir Crit Care Med. 1998;157:1951-1958
33. Remy-Jardin M, Bouaziz N, Dumont P, et al. Bronchial and nonbronchial systemic arteries at multi-detector row CT angiography: Comparison with conventional angiography. Radiology. 2004;233:741-749
34. Flume PA, Mogayzel PJ Jr, Robinson KA, et al. Cystic fibrosis pulmonary guidelines: Pulmonary complications: Hemoptysis and pneumothorax. Am J Respir Crit Care Med. 2010;182: 298-306
35. Puderbach M, Eichinger M, Haeselbarth J, et al. MRI for early diagnosis of lung changes in children with cystic fibrosis. Am J Resp Crit Care Med. 2008;177:224
36. Hansell DM. Small airways diseases: Detection and insights with computed tomography. Eur Respir J. 2001;17:1294-1313
37. Fink C, Ley S, Kroeker R, et al. Time-resolved contrastenhanced three-dimensional magnetic resonance angiography of the chest: Combination of parallel imaging with view sharing (TREAT). Invest Radiol. 2005;40:40-48
38. Molinari F, Fink C, Risse F, et al. Assessment of differential pulmonary blood flow using perfusion magnetic resonance imaging: Comparison with radionuclide perfusion scintigraphy. Invest Radiol. 2006;41:624-630
39. Fink C, Ley S, Schoenberg SO, et al. Magnetic resonance imaging of acute pulmonary embolism. Eur Radiol. 2007; 17:2546-2553
40. Thabut G, Dauriat G, Stern JB, et al. Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation. Chest. 2005; 127:1531-1536
41. Morino S, Toba T, Araki M, et al. Noninvasive assessment of pulmonary emphysema using dynamic contrast-enhanced magnetic resonance imaging. Exp Lung Res. 2006;32:55-67
42. Eichinger M, Puderbach M, Fink C, et al. Contrast-enhanced 3D MRI of lung perfusion in children with cystic fibrosis -initial results. Eur Radiol. 2006;16:2147-2152
43. Bankier AA, O'Donnell CR, Mai VM, et al. Impact of lung volume on MR signal intensity changes of the lung parenchyma. J Magn Reson Imaging. 2004;20:961-966
44. Hopkins SR, Henderson AC, Levin DL, et al. Vertical gradients in regional lung density and perfusion in the supine human lung: The Slinky effect. J Appl Physiol. 2007;103: 240-248
45. Jakob PM, Hillenbrand CM,Wang T, et al. Rapid quantitative lung (1)H T(1) mapping. J Magn Reson Imaging. 2001;14: 795-799
46. Stadler A, Jakob PM, Griswold M, et al. T1 mapping of the entire lung parenchyma: Influence of respiratory phase and correlation to lung function test results in patients with diffuse lung disease. Magn Reson Med. 2008;59:96-101
47. Mosbah K, Ruiz-Cabello J, Berthezene Y, et al. Aerosols and gaseous contrast agents for magnetic resonance imaging of the lung. Contrast Media Mol Imaging. 2008;3:173-190
48. Haage P, Karaagac S, Spuntrup E, et al. Feasibility of pulmonary ventilation visualization with aerosolized magnetic resonance contrast media. Invest Radiol. 2005;40:85-88
49. Altes TA, de Lange EE. Applications of hyperpolarized helium-3 gas magnetic resonance imaging in pediatric lung disease. Top Magn Reson Imaging. 2003;14:231-236
50. van Beek EJ, Wild JM, Kauczor HU, et al. Functional MRI of the lung using hyperpolarized 3-helium gas. J Magn Reson Imaging. 2004;20:540-554
51. Altes TA, Rehm PK, Harrell F, et al. Ventilation imaging of the lung: Comparison of hyperpolarized helium-3 MR imaging with Xe-133 scintigraphy. Acad Radiol. 2004;11:729-734
52. Kauczor HU. Hyperpolarized helium-3 gas magnetic resonance imaging of the lung. Top Magn Reson Imaging. 2003; 14:223-230
53. Ley S, Zaporozhan J, Morbach A, et al. Functional evaluation of emphysema using diffusion-weighted 3Helium-magnetic resonance imaging, high-resolution computed tomography, and lung function tests. Invest Radiol. 2004;39:427-434
54. Mentore K, Froh DK, de Lange EE, et al. Hyperpolarized HHe 3 MRI of the lung in cystic fibrosis: Assessment at baseline and after bronchodilator and airway clearance treatment. Acad Radiol. 2005;12:1423-1429
55. van Beek EJ, Hill C, Woodhouse N, et al. Assessment of lung disease in children with cystic fibrosis using hyperpolarized 3-helium MRI: Comparison with Shwachman score, Chrispin-Norman score and spirometry. Eur Radiol. 2007;17: 1018-1024
56. Bannier E, Cieslar K, Mosbah K, et al. Hyperpolarized 3He MR for sensitive imaging of ventilation function and treatment efficiency in young cystic fibrosis patients with normal lung function. Radiology. 2010;255:225-232
57. Edelman RR, Hatabu H, Tadamura E, et al. Noninvasive assessment of regional ventilation in the human lung using oxygen-enhanced magnetic resonance imaging. Nat Med. 1996;2:1236-1239
58. Ohno Y, Chen Q, Hatabu H. Oxygen-enhanced magnetic resonance ventilation imaging of lung. Eur J Radiol. 2001; 37:164-171
59. Keilholz S, Knight-Scott J, Mata J, et al. The contributions of ventilation and perfusion in O2-enhanced MRI. In: Proc 10th Annual Meeting ISMRM, Honolulu; 2002
60. Ley S, Puderbach M, Risse F, et al. Impact of oxygen inhalation on the pulmonary circulation: Assessment by magnetic resonance (MR)-perfusion and MR-flow measurements. Invest Radiol. 2007;42:283-290
61. Jakob PM, Wang T, Schultz G, et al. Assessment of human pulmonary function using oxygen-enhanced T(1) imaging in patients with cystic fibrosis.Magn ResonMed. 2004;51:1009-1016
62. Buxton RB. Quantifying CBF with arterial spin labeling. J Magn Reson Imaging. 2005;22:723-726
63. Mai VM, Hagspiel KD, Christopher JM, et al. Perfusion imaging of the human lung using flow-sensitive alternating inversion recovery with an extra radiofrequency pulse (FAIRER). Magn Reson Imaging. 1999;17:355-361
64. Bauman G, Puderbach M, Deimling M, et al. Non-contrastenhanced perfusion and ventilation assessment of the human lung by means of fourier decomposition in proton MRI. Magn Reson Med. 2009;62:656-664
65. Bauman G, Eichinger M. Ventilation and perfusion magnetic resonance imaging of the lung. Pol J Radiol. 2012;77:37-46
66. Bauman G, Lutzen U, Ullrich M, et al. Pulmonary functional imaging: Qualitative comparison of fourier decomposition MR Imaging with SPECT/CT in porcine lung. Radiology. 2011;260:551-559
67. Bauman G, Scholz A, Rivoire J, et al. Lung ventilation-And perfusion-weighted Fourier decomposition magnetic resonance imaging: In vivo validation with hyperpolarized (3) He and dynamic contrast-enhanced MRI. Magn Reson Med. 2013;69:229-237
68. Bauman G, Eichinger M, Deimling M. Non-contrast-enhanced lung perfusion MRI in comparison to contrast-enhanced MRI perfusion in young cystic fibrosis patients. Insight Imaging. 2010;(1 Suppl. 1):S301
69. Henderson AC, Ingenito EP, Salcedo ES, et al. Dynamic lung mechanics in late-stage emphysema before and after lung volume reduction surgery. Respir Physiol Neurobiol. 2007;155:234-242
70. Cluzel P, Similowski T, Chartrand-Lefebvre C, et al. Diaphragm and chest wall: Assessment of the inspiratory pump with MR imaging-preliminary observations. Radiology. 2000; 215:574-583
71. Plathow C, Ley S, Fink C, et al. Evaluation of chest motion and volumetry during the breathing cycle by dynamic MRI in healthy subjects: Comparison with pulmonary function tests. Invest Radiol. 2004;39:202-209
72. Plathow C, Schoebinger M, Fink C, et al. Evaluation of lung volumetry using dynamic three-dimensional magnetic resonance imaging. Invest Radiol. 2005;40:173-179
73. Tetzlaff R, Schwarz T, Kauczor HU, et al. Lung function measurement of single lungs by lung area segmentation on 2D dynamic MRI. Acad Radiol. 2010;17:496-503
74. Tokuda J, Schmitt M, Sun Y, et al. Lung motion and volume measurement by dynamic 3D MRI using a 128-channel receiver coil. Acad Radiol. 2009;16:22-27
75. Chrispin AR, Norman AP. The systematic evaluation of the chest radiograph in cystic fibrosis. Pediatr Radiol. 1974;2:101-105
76. Bhalla M, Turcios N, Aponte V, et al. Cystic fibrosis: Scoring system with thin-section CT. Radiology. 1991;179:783-788
77. de Jong PA, Ottink MD, Robben SG, et al. Pulmonary disease assessment in cystic fibrosis: Comparison of CT scoring systems and value of bronchial and arterial dimension measurements. Radiology. 2004;231:434-439
78. Brody AS, Molina PL, Klein JS, et al. High-resolution computed tomography of the chest in children with cystic fibrosis: Support for use as an outcome surrogate. Pediatr Radiol. 1999;29:731-735
79. Tiddens HA, de Jong PA. Imaging and clinical trials in cystic fibrosis. Proc Am Thorac Soc. 2007;4:343-346
80. de Jong PA, Nakano Y, Hop WC, et al. Changes in airway dimensions on computed tomography scans of children with cystic fibrosis. Am J Respir Crit Care Med. 2005;172:218-224
81. Wielpütz MO, Eichinger M, Weinheimer O, et al. Automatic airway analysis on multidetector computed tomography in cystic fibrosis -correlation with pulmonary function testing. J Thorac Imaging. 2013;28:104-113
82. Heimann T, Eichinger M, Bauman G, et al. Automated scoring of regional lung perfusion in children from contrast enhanced 3D MRI. Proceedings of SPIE. San Diego, CA, USA; 2012:8315-8329
83. Bauman G, Heimann T, Fritzsching E, et al. Automated Assessment of Regional Lung Perfusion in Cystic Fibrosis Patients by Using Fourier Decomposition MRI. In: Proc 20th Annual Meeting ISMRM, Melbourne; 2012
84. Kuder TA, Risse F, Eichinger M, et al. New method for 3D parametric visualization of contrast-enhanced pulmonary perfusion MRI data. Eur Radiol. 2008;18:291-297
85. Kohlmann P, Jobst B, Sedlaczek O, et al. Validation of an automatic lung segmentation method for MRI-based lung perfusion studies. J Thorac Imaging. 2012;27:W124-W125
86. Ohno Y, Hatabu H, Murase K, et al. Quantitative assessment of regional pulmonary perfusion in the entire lung using threedimensional ultrafast dynamic contrast-enhanced magnetic resonance imaging: Preliminary experience in 40 subjects. J Magn Reson Imaging. 2004;20:353-365
87. Neeb D, Kunz RP, Ley S, et al. Quantification of pulmonary blood flow (PBF): Validation of perfusion MRI and nonlinear contrast agent (CA) dose correction with H(2)15O positron emission tomography (PET). Magn Reson Med. 2009;62:476-487
88. Ley S, Mereles D, Risse F, et al. Quantitative 3D pulmonary MR-perfusion in patients with pulmonary arterial hypertension: Correlation with invasive pressure measurements. Eur J Radiol. 2007;61:251-255
89. Puderbach M, Risse F, Biederer J, et al. In vivo Gd-DTPA concentration for MR lung perfusion measurements: Assessment with computed tomography in a porcine model. Eur Radiol. 2008;18:2102-2107
90. Risse F, Eichinger M, Kauczor HU, et al. Improved visualization of delayed perfusion in lung MRI. Eur J Radiol. 2011; 77:105-110